To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) (PAR-25-2

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) (RFA-MH-26-140)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) (PAR-25-058)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) (PAR-25-059)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) (PAR-25-0

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Notice of Intent to Publish a Notice of Funding Opportunity for Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed) (NOT-AG-24-077)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: November 25, 2024. First Estimated Application Due Date: February 14, 2025.

Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015)

Sponsor: National Institutes of Health

Due Date: January 24, 2025.

Notice of Special Interest (NOSI): National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) (NOT-GM-24-056)

Sponsor: National Institute Health

Due Date: First Available Due Date: January 25, 2025. Expiration Date: September 26, 2026.

Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed) (RFA-NS-24-038)

Sponsor: National Institutes of Health

Award: Annual direct costs may not exceed $1M. The maximum project duration for this Pilot Project is 3 years.

Due Date: Letter of Intent due January 14, 2025. Application due February 14, 2025.

Notice of Special Interest (NOSI): Ruth L. Kirschstein NRSA Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project (NOT-OD-24-143)

Sponsor: National Institutes of Health

Due Date: This notice applies to due dates on or after December 8, 2024 and subsequent receipt dates through September 8, 2027.

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) (PAR-25-055)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D&E Centers) (P30 Clinical Trial Optional) (RFA-AG-25-007)

Sponsor: National Institute on Aging

Due Date: Letter of Intent due December 10, 2024. Application due January 10, 2025.

Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional) (RFA-AG-25-008)

Sponsor: National Institute on Aging

Due Date: Letter of Intent due December 10, 2024. Application due January 10, 2025.

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) (PAR-25-050)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): The Role of the Immune System in Aging Brain and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-24-010)

Sponsor: National Institute on Aging, National Institute of Allergy and Infectious Diseases

Award: This initiative relates to the following notices of funding opportunities (NOFOs): PAR-22-093 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional); PAR-22-094 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional).

Due Date: This notice applies to due dates on or after November 12, 2024 and subsequent receipt dates through December 31, 2027.

Go to another page:

2
3
4
5
6
... 10

Current Filters

Keyword: notice-information-technical-assistance-webinars-rfa-ns-25-024-amyotrophic-lateral-sclerosis x

Remove all filters

GRANTS

Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) (PAR-25-2

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) (RFA-MH-26-140)

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) (PAR-25-058)

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) (PAR-25-059)

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) (PAR-25-0

Notice of Intent to Publish a Notice of Funding Opportunity for Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed) (NOT-AG-24-077)

Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015)

Notice of Special Interest (NOSI): National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) (NOT-GM-24-056)

Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed) (RFA-NS-24-038)

Notice of Special Interest (NOSI): Ruth L. Kirschstein NRSA Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project (NOT-OD-24-143)

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) (PAR-25-055)

Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D&E Centers) (P30 Clinical Trial Optional) (RFA-AG-25-007)

Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional) (RFA-AG-25-008)

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) (PAR-25-050)

Notice of Special Interest (NOSI): The Role of the Immune System in Aging Brain and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-24-010)

Current Filters

Filter By